Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20873)

• Formulation Name: Temozolomide 250 mg capsule
• Company: Merck Sharp & Dohme

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Temozolomide	(DMKECZD)	Adenocarcinoma	2D40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonia	(E00007)	222	Alkalizing agent
Butyl alcohol	(E00011)	263	Flavoring agent; Solvent
Eisenoxyd	(E00585)	56841934	Colorant
Isopropyl alcohol	(E00070)	3776	Antimicrobial preservative; Solvent
Potassium hydroxide	(E00233)	14797	Alkalizing agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent